ACE2 homolog of angiotensin converting enzyme regulatory update

MLNM received U.S. Patent No. 6,194,556 covering the use of the ACE2 gene to develop therapeutics and predictive medicine products. MLNM said that ACE2 may represent a target to treat hypertension and...